Specifically, we addressed the effect of LTI-2355 on both the functional and synthetic properties of adherent CD45+ myeloid cells enriched from healthy donors and lung explants from IPF and PASC-F patients. The gene discussed is PTPRC; the disease is idiopathic pulmonary fibrosis.